Search Results for 'Olaparib Brca'

Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing

• alexa-scheidler
• 15 Slides

Phase I Study of Olaparib and Temozolomide, in pa...

• littleccas
• 21 Slides

actual. . video-recorded proceedings from the . l...

Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i

• zen
• 21 Slides

knowledge. ). Incorporate evidence-based research ...

Ovarian cancer update Kentucky cancer Registry

• danika-pritchard
• 0 Slides

9/8/2016 . Erica . Takimoto. , D.O., F.A.C.O.O.G....

Updates in Ovarian Cancer Care

• tatiana-dople
• 0 Slides

Lisa McCluskey, MD. Gynecologic Oncologist. June ...

PARP Inhibitors This program will include a discussion of off-label treatment and investigational a

• conchita-marotz
• 0 Slides

PARP Inhibitors: What Do We know?. PARP Inhibitor...

Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic Ewing

• karlyn-bohler
• 15 Slides

Phase I Study of Olaparib and Temozolomide, in pa...

PARP Inhibitors and Cancer: What Do You Need to Know?

• pasty-toler
• 0 Slides

This program will include a discussion of off-lab...

NEw developments IN gynecological Oncology

• cheryl-pisano
• 211 Slides

highlights from the. EUROPEAN . society . of med...

Updates in Ovarian Cancer Care

• ellena-manuel
• 55 Slides

Lisa McCluskey, MD. Gynecologic Oncologist. June ...

Genomic Prostate Cancer Testing for Olaparib

• abigail
• 24 Slides

Laura Yarram-Smith . Solid Tumour Lead SWGLH. J...

GU CONNECT PARP inhibitors in Prostate Cancer

• jocelyn
• 36 Slides

Latest developments. . Prof.. . Neeraj Agarwal, ...

Year in Review Prostate Cancer

• faith
• 30 Slides

Emmanuel . S . Antonarakis. , MD. Professor of Onc...

What Clinicians Want to Know:

• violet
• 51 Slides

Understanding the Factors Affecting the Optimal Di...